Answers are grounded in this paper and cite their sources.
Genome-reduced Bacillus subtilis ∆6 shows improved surfactin production, indicating significant metabolic changes.
Bacillus subtilis ∆6 is a genome-reduced strain derived from the laboratory strain 168 through deletion of six prophages and AT-rich islands. The parental and the genome-reduced strains were edited to restore the capacity to synthesize surfactin. Although the genome deletions are not directly related to surfactin biosynthesis, the ∆6 strain produces more surfactin while building lower biomass compared to the parental strain. Further editions to ∆6, such as srfA promoter replacement, codY deletion, and comA overexpression, were deleterious to surfactin production. The results showcase that the ∆6 is metabolically distinct from its parental strain and other surfactin-producing strains, as the gene editions made have been previously described to increase surfactin production in these strains. The ∆6 produced the highest surfactin titer, rate, and yield in LB medium enriched with glucose, compared to other commonly used media for B. subtilis. This work demonstrates the enhanced capacity of a genome-reduced strain to produce surfactin compared to the parental strain, as well as the metabolic changes resulting from genome engineering.
No takes yet. Share an insight, caveat, or question.
Zocca et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: